Literature DB >> 20148562

5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.

Chih-Ying Nien1, Yun-Ching Chen, Ching-Chuan Kuo, Hsing-Pang Hsieh, Chi-Yen Chang, Jian-Sung Wu, Su-Ying Wu, Jing-Ping Liou, Jang-Yang Chang.   

Abstract

A series of aroylquinoline derivatives were synthesized and evaluated for anticancer activity. 5-Amino-6-methoxy-2-aroylquinoline 15 showed more potent antiproliferative activity (IC(50) values ranging from 0.2 to 0.4 nM) as compared to 1a (combretastatin A-4) (IC(50) = 1.9-835 nM) against various human cancer cell lines and a MDR-resistant cancer cell line. Compound 15 (IC(50) = 1.6 microM) exhibited more potent inhibition of tubulin polymerization than 1a (IC(50) = 2.1 microM) and showed strong binding property to the colchicine binding site of microtubules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148562     DOI: 10.1021/jm900685y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

2.  Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization.

Authors:  Jianjun Chen; Chien-Ming Li; Jin Wang; Sunjoo Ahn; Zhao Wang; Yan Lu; James T Dalton; Duane D Miller; Wei Li
Journal:  Bioorg Med Chem       Date:  2011-07-01       Impact factor: 3.641

3.  Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.

Authors:  Renaud Prudent; Émilie Vassal-Stermann; Chi-Hung Nguyen; Marjorie Mollaret; Jean Viallet; Agnès Desroches-Castan; Anne Martinez; Caroline Barette; Catherine Pillet; Glaucio Valdameri; Emmanuelle Soleilhac; Attilio Di Pietro; Jean-Jacques Feige; Marc Billaud; Jean-Claude Florent; Laurence Lafanechère
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 4.  Cytoskeleton-Dependent Transport as a Potential Target for Interfering with Post-transcriptional HuR mRNA Regulons.

Authors:  Wolfgang Eberhardt; Amel Badawi; Abhiruchi Biyanee; Josef Pfeilschifter
Journal:  Front Pharmacol       Date:  2016-08-17       Impact factor: 5.810

5.  Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.

Authors:  I-Ting Tsai; Ching-Chuan Kuo; Jing-Ping Liou; Jang-Yang Chang
Journal:  J Biomed Sci       Date:  2018-03-28       Impact factor: 8.410

6.  Synthesis and biological evaluation of 4-aroyl-6,7,8-trimethoxyquinolines as a novel class of anticancer agents.

Authors:  Cheng-Chih Hsieh; Hsueh-Yun Lee; Chih-Ying Nien; Ching-Chuan Kuo; Chi-Yen Chang; Jang-Yang Chang; Jing-Ping Liou
Journal:  Molecules       Date:  2011-03-07       Impact factor: 4.411

7.  A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway.

Authors:  Nai-Jung Chiang; Ching-I Lin; Jing-Ping Liou; Ching-Chuan Kuo; Chi-Yen Chang; Li-Tzong Chen; Jang-Yang Chang
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

8.  Combretastatin A-4 efficiently inhibits angiogenesis and induces neuronal apoptosis in zebrafish.

Authors:  Yun-Wei Shi; Wei Yuan; Xin Wang; Jie Gong; Shun-Xing Zhu; Lin-Lin Chai; Jia-Ling Qi; Yin-Yin Qin; Yu Gao; Yu-Ling Zhou; Xiao-Le Fan; Chun-Ya Ji; Jia-Yi Wu; Zhi-Wei Wang; Dong Liu
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.